Showing results (2121-2130 of 4,401) with videos related to
Sort By:
Pageof 441
ACS Medicinal Chemistry Letters|February 21, 2015
Development and Preliminary Evaluation of TFIB, a New Bimodal Prosthetic Group for Bioactive Molecule LabelingEmilie M F Billaud, Aurélien Vidal, Amélie Vincenot, et al.ACS Medicinal Chemistry Letters|May 31, 2021
Characterization and Optimization of Benzimidazopyrimidine and Pyridoimidazopyridine Derivatives as Tau-SPECT ProbesHiroyuki Watanabe, Takeaki Kishimoto, Sho Kaide, et al.ACS Medicinal Chemistry Letters|July 14, 2026
The Development of UM-232, a Covalent STING AntagonistLeonard Barasa, Leo DeOrsey, Maeve D O'Reilly, et al.ACS Medicinal Chemistry Letters|July 14, 2026
A Dual-Action Gold(I) Prodrug Targeting Redox Homeostasis and Extracellular Matrix Remodeling in Ovarian CancerRiccardo Di Leo, Enrico Crispino, Lorenzo Chiaverini, et al.ACS Medicinal Chemistry Letters|July 14, 2026
Novel Compounds as SARS-CoV‑2 Main Protease Inhibitors for Treating Viral Infections, in particular, Coronavirus InfectionsRam W SabnisACS Medicinal Chemistry Letters|July 14, 2026
Discovery of Biased Dual-Agonists of Glucagon-Like Peptide 1 and Glucagon Receptors through Mutation of a Conserved AspartateRobert E Thompson, Aditya J Desai, Dmitri Pissarnitski, et al.ACS Medicinal Chemistry Letters|July 14, 2026
Identification of Clofibric Acid as a Synoviolin (SYVN1) Ligand for Proteolysis-Targeting Chimera (PROTAC) DevelopmentJulia Warren, Anandarao Munakala, Keith D Zientek, et al.ACS Medicinal Chemistry Letters|July 14, 2026
Development of Selective PARP1 Inhibitors for the Treatment of CancerXin Zhou, Steven H LiangACS Medicinal Chemistry Letters|July 14, 2026
Discovery of MK-2118, a Small-Molecule Agonist of STINGTimothy Henderson, Michael D Altman, Alexei V Buevich, et al.ACS Medicinal Chemistry Letters|July 14, 2026
Novel Compounds for Inhibiting Viral Replication and Treating and/or Preventing Coronavirus InfectionsRam W SabnisPageof 441